AAV Vector Production

September 4, 2018 ||
Overview Until about 2016, the majority of vectors used in gene therapy were Adenovirus and Retrovirus vectors.  In recent years, a change toward Lentivirus and Adeno-associated virus (AAV) vectors has occurred.  This is reflected when looking at the numbers in current clinical trials underway in the gene therapy field.